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Abstract – Of the many risk factors suggested for sudden unexpected death in epilepsy (SUDEP), higher 
frequency of seizures is a very consistent issue. Following this reasoning, it has been established that 
hemodialysis-associated seizure is a complication of dialysis procedure. Based on these facts, this study 
investigated a possible association between cardiovascular abnormalities and SUDEP among patients with 
chronic renal insufficiency in regular hemodialysis program. For that, a retrospective medical history of 209 
patients was reviewed to investigate the occurrence of convulsive seizures and EKG abnormalities during 
dialytic program. Three patients presented generalized tonic-clonic seizures, one had partial seizure with 
secondary generalization, and one presented unclassified seizure. Any EKG abnormalities and SUDEP event were 
found in all patients evaluated. In conclusion, the present findings demonstrated uncommon the occurrence 
of seizures and also SUDEP. Probably, the main justification to not allow us to demonstrated a direct relation 
between SUDEP and cardiovascular diseases in hemodialysis are the reduced number of cases examined.
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Existe algo de especial a respeito das anormalidades cardíacas e morte súbita e inesperada na epilepsia 
nos pacientes com insuficiência renal crônica no programa regular de hemodiálise? 
Resumo – Um dos principais fatores de risco para a morte súbita e inesperada na epilepsia (SUDEP) é a alta 
freqüência de crises epilépticas. Seguindo este raciocínio, tem sido estabelecido que as crises epilépticas 
associadas à hemodiálise seja uma complicação do procedimento dialítico. Baseado neste fato, este estudo 
investigou uma possível associação entre anormalidades cardiovasculares e SUDEP nos pacientes com 
insuficiência renal crônica em um programa regular de hemodiálise. Para isto, um histórico médico retrospectivo 
de 209 pacientes foi revisado para avaliar a ocorrência de crises epilépticas e possíveis anormalidades no 
ECG durante o programa de diálise. Três pacientes apresentaram crises tônico-clonica generalizadas, um 
apresentou crise parcial com generalização secundária e um apresentou crise não-classificada. Não detectamos 
anormalidades no ECG e ocorrência de SUDEP em todos os pacientes avaliados. Em conclusão, na presente 
amostra constatou-se como rara a ocorrência de crises epilépticas e SUDEP. Provavelmente, o número reduzido 
de casos avaliados tenha sido responsável pela não observação de uma relação direta entre SUDEP e as doenças 
cardiovasculares na hemodiálise.
PAlAvrAS-ChAvE: epilepsia, morte súbita, coração, crises epilépticas, hemodiálise.
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Approximately epilepsy is the most common seri-
ous neurological condition and almost 50 million people 
worldwide have epilepsy1-3. The most common risk factors 
for epilepsy are cerebrovascular diseases, brain tumours, 
alcohol, traumatic head injuries, malformations of cortical 
development, genetic inheritance and infections of the 
central nervous system4. In resource-poor countries, en-
demic infections, such as malaria and neurocysticercosis 
seem to be major risk factors5. Actually, clinical data sup-
port that people with epilepsy are two- to three-fold in-
crease to die prematurely than those without epilepsy and 
the most common epilepsy-related category of death is 
sudden unexpected death in epilepsy (SUDEP)6,7. Informa-
tion concerning risk factors for SUDEP is conflicting, but 
potential risk factors include: age, early onset of epilep-
sy, duration of epilepsy, uncontrolled seizures, seizure fre-
quency, seizure type, antiepileptic drugs number and win-
ter temperatures6. Additionally, the underlying pathophys-
iology of SUDEP is unknown; however, it is very probable 
that cardiac arrhythmia play a potential role. In this way, 
rugg-Gunn and collaborators8 using implantable loop re-
corders demonstrated that some patients with refracto-
ry partial epilepsy may have potentially life-threatening 
cardiac arrhythmias. Moreover, it has been established 
that repetitive seizures can alter the regulation of cardi-
ac activity by the autonomic nervous system (ANS), and 
ANS dysregulation is thought to be associated with higher 
morbidity and mortality in patients with epilepsy9. In ac-
cordance with this reasoning, we postulated the question: 
is there a possible relation between epilepsy, renal dys-
function, cardiovascular abnormalities and hence SUDEP?
Cardiac disease is the major cause of death in patients 
with end-stage of renal disease, accounting for approx-
imately 43% of all deaths10,11. In dialysis patients, about 
20% of cardiac deaths are attributed to acute myocardi-
al infarction, a catastrophic clinical event in this group of 
patients10,12. In parallel, it has been reported an estimat-
ed incidence of seizure of approximately 10% in patients 
with chronic renal failure13. In addition, Plum and Posner14 
also noted that convulsions occurred in one third of pa-
tients with end-stage renal disease (ESrD) and was fre-
quently a preterminal event. The seizures in these series 
usually were generalized tonic-clonic type; however, the 
mechanism of reduced seizure threshold in renal failure 
is still unknown. hemodialysis-associated seizure (hAS) 
is a common complication of hemodialysis15. hAS occurs 
in 7% to 50% of children with ESrD, and their seizures 
are usually reported as generalized tonic-clonic seizures16. 
risk factors for hAS include young age, prior history of 
seizures, malignant hypertension, microvascular diseases, 
uremic encephalopathy and cardiomyopathy. Moreover, 
induced brain water disequilibrium, hypocalcaemia, ure-
mic toxins, the use of acetate in the dialysate, intracrani-
al hemorrhage due to systemic heparinization, treatment 
with recombinant erythropoietin, hemodynamic and met-
abolic defects, and drugs such as penicillin and theophill-
ine are also considered responsible for hAS16-18. If all these 
data are taken together, information on the management 
of seizures in renal failure should be disseminated among 
professionals treating systemic diseases. Based on these 
facts, we are interested here in exploring the occurrence 
of epilepsy and hence sudden unexpected death in pa-
tients with chronic renal insufficiency under regular he-
modialysis program. 
METHOD
A retrospective medical history of 209 patients was re-
viewed to investigate the occurrence epilepsy, cardiovascu-
lar abnormalities and hence sudden unexpected death in dial-
ysis patients at the Nephrology Institute of Mogi das Cruzes. 
From 209 patients under dialytic treatment, 7 had suffered some 
type of convulsive seizure and were invited to participate in the 
study, but only 5 patients had agreed to participate. They were 
4 males and 1 female, with a mean age of 42 years (range: 20 to 
72 years old). The five patients have severe systemic arterial hy-
pertension and were using antihypertensive drugs. In our clinic, 
all patients have monthly evaluation of total calcium and were 
receiving calcium carbonate (CaCO3). The solution for the dia-
lytic treatment contains 210.7g/l of NaCl, with a calcium con-
centration of 2.5 or 3.5 mEq/l.
All patients were evaluated for initial disease, duration, type 
and frequency of hAS and then submitted to clinical and neu-
rological examination. The mean time of dialysis treatment and 
the electroencephalography (EEG) was analysed in all patients. 
The seizures were classified according the Commission on Clas-
sification and Terminology of International league Against Ep-
ilepsy19. The possible seizure triggering factors, such as the use 
or withdrawal of medications, sleep deprivation, arterial hyper-
tension, infections, and electrolytic misbalance, especially hy-
pocalcaemia, were also investigated. 
EKG data for all patients was obtained from one or two 
EKG channels (used routinely at our center) utilizing two EKG 
electrodes. EKG electrodes were usually placed on the anterior 
chest, one on each side, though exact positioning was not stan-
dardized. EKG abnormalities were reviewed by a board certified 
physician (rAG, Director of the Nephrology Institute of Mo-
gi das Cruzes). we would like to point out that part of the data 
used in the present study have already been published in a previ-
ous work developed by our research group20. The study received 
approval from the human research Ethics Committee, and all 
subjects signed an informed consent document.
RESULTS
In our study we analyzed the data of 5 out of 209 pa-
tients recruited under dialytic treatment at the Nephrol-
ogy Institute of Mogi das Cruzes. All five patients had se-
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vere systemic arterial hypertension and were using antihy-
pertensive drugs. These patients were also using antiepi-
leptic drug (phenytoin 200 mg/daily) and CaCO3 (1.500 
mg/daily). The mean age of beginning of dialysis was 25 
years. The mean duration of dialytic treatment was 5.8 
years (range: 2 to 12 years). The causes of renal failure 
were diabetic nephropathy (4 patients) and chronic glom-
erolonephritis (1 patient) (Table 1). All patients had normal 
aluminum plasma levels and were not affected by other 
clinical pictures that could be led to possible aluminum 
intoxication. The signs of Chvostek and Trousseau were 
absent in all patients and the neurological examination 
was normal in 4 patients, but one presented pyramidal 
syndrome (left hemiparesia with pyramidal signs), with ab-
normal CT scan (hipodensity on right temporal lobe).
The seizure history of the five patients is listed on Ta-
ble 2. Briefly, three patients presented generalized ton-
ic-clonic seizures, one presented partial seizure with sec-
ondary generalization, and one presented unclassified sei-
zure. All patients had seizures at home, two patients had 
seizures during dialysis procedure and one of them had 
presented convulsive status epilepticus. Two patients had 
already presented seizures prior the beginning of dialy-
sis treatment; one of them without detectable structur-
al CNS lesion, and the other showed hipodensity on right 
temporal lobe (vascular cerebral disease). All patients pre-
sented normal interictal EEG. At time of seizure, none of 
them presented infection, electrolytic misbalance (hy-
pocalcemia), sleep deprivation, stress situation or were us-
ing pharmacological agents that lower the seizure thresh-
old and can cause seizures, such as theophylline, antipsy-
chotics and antidepressants. Any EKG abnormality and se-
rious abnormalities were found in all patients evaluated 
by a board certified physician. 
DISCUSSION
The primary aim of this study was to verify the possi-
ble association between epilepsy and hence sudden un-
expected death in patients with chronic renal insufficien-
cy under regular hemodialysis program. we note the cas-
es evaluated (5 out of 209) that cardiovascular altera-
tions and hence SUDEP is not a common event. Never-
theless, these findings need to be interpreted with cau-
tion. The study has methodological limitations; howev-
er, as research in this field must be guided by the poten-
tial for the prevention of SUDEP, a number of arguments 
might be put forward. 
Firstly, it has long been believed that seizures are rel-
atively a common complication of hemodialysis15. how-
ever, in our study we observed the occurrence of hAS in 
only 2% of our patients. In these lines, our results are not 
in agreement with previous studies, which related an es-
timated incidence of seizure of approximately 10% in pa-
tients with chronic renal failure13. Concerning the small-
er occurrence of seizures in our patients and the no pres-
ence of SUDEP among them, we can pointed here that 
of the many risk factors suggested for SUDEP, higher fre-
quency of seizures is a very consistent issue. According-
ly, among the rarely witnessed cases of SUDEP, the ma-
jority of patients proved to suffer a partial or general-
ized seizure immediately prior to death, suggesting a sei-
zure-related cardiac or respiratory dysfunction21. More-
over, SUDEP is a rare event in patients in remission and 
only few such cases have been described22,23. In an elegant 
largest case-control study, Nilsson and colleagues dem-
onstrated that seizure frequency is a strongest risk factor 
for SUDEP24. In their study, 57 SUDEP cases were included, 
of whom 91% had undergone necropsy. The relative risk 
of SUDEP increased with number of seizures per year and 
the estimated relative risk was 10.16 (95% CI 2.94–35.18) in 
patients with more than 50 seizures per year, compared 
with those with up to two seizures per year. 
with regard the second argument, in spite of reports 
Table 1. Specific causes of end-stage of renal disease (Adapted by 
permission of the authors20).
Patient Age Gender Causes of end-stage of renal disease
ADS 23 Female Chronic glomerulonephritis
rDS 20 Male Diabetic nephropathy
OrC 45 Male Diabetic nephropathy
lCO 43 Male Diabetic nephropathy
SAJ 72 Male Diabetic nephropathy
Table 2. Seizure history of the patients during regular hemodialysis program (Adapted by permission of the authors20).
Patient
Seizures 
(dialysis procedure)
Seizures 
(home) Seizure’s types Seizure’s frequency
ADS yes yes Unclassified Five
rDS yes yes Generalized tonic-clonic Twice
OrC No yes Generalized tonic-clonic Unique
lCO No yes Generalized tonic-clonic Unique
SAJ No yes Partial with secondary generalization Unique
Arq Neuropsiquiatr 2009;67(2-A)
212
Sudden death in epilepsy
Gomes et al.
that prior history of seizure did influence the risk of sei-
zures among patients receiving hemodialysis16, we did not 
observe higher risk in our patients who had prior history 
of epilepsy. It is difficult to make comparisons between 
our with other studies since different factors may influ-
ence the analysis, such as the age of the subjects, type 
of seizures and risk factors for hAS as previously men-
tioned. In the same way and thinking about no presence of 
SUDEP in our study, it has been known that SUDEP appears 
to be an issue mainly in patients with chronic epilepsy22. 
we note in all cases evaluated (5 out of 209) that only 
two patients had already presented isolated seizures pri-
or the beginning of dialysis treatment, not characterizing 
long duration of epilepsy in these cases. Our results are in 
agreement with previous studies that report a mean du-
ration of the seizure disorder ranging from 15 to 20 years 
in SUDEP cases22.
Third, SUDEP is usually unwitnessed, but when wit-
nessed, all studies that have identified the patients’ sei-
zure type report a history of primary or secondary gen-
eralized tonic-clonic seizures (GTCS) in at least 90% of 
SUDEP cases22,25. Although three patients presented GTCS 
in our study, these seizures were isolated and no SUDEP 
cases were found. Following this reasoning, our results are 
totally in agreement with the elegant study of Birnbach 
and colleagues that comparing people with epilepsy who 
died with those who survived, described that majority of 
those who died had a history of GTSC and that the fre-
quency of GTCS was greater in those who died26.
Finally, age is another interesting risk factor for SUDEP 
that could be explored in our study. The age of reported 
cases of SUDEP have ranged from 8 months to 83 years, 
however, the great majority of studies have been shown 
that mean ages of SUDEP range from 26 to 37 years21,22,25,27. 
In these lines, one explanation about the reason that we 
did not find SUDEP cases in our study is because the age of 
each patient evaluated by us is not related with the mean 
age of SUDEP occurrence. Moreover, it is important to note 
that some studies have found different decades of peak of 
incidence of SUDEP25 and although our study did not asso-
ciated the relation between age and SUDEP, we could not 
make statements concerning the SUDEP risk factor relat-
ed to age in our cases for epileptic population in general.
In conclusion, the results of present study are total-
ly in agreement with our earlier research, demonstrat-
ing that seizures in renal failure continuous been consid-
ered an occasional event that does not usually become 
chronic20. In this sense, we are sure that information on 
the management of seizures in renal failure and the pos-
sibility of SUDEP occurrence among patients with end-
stage of renal disease should be disseminated among pro-
fessionals treating systemic diseases. In sum, we also be-
lieve that neurologist should be aware about cardiovas-
cular abnormalities and hence SUDEP in patients with ep-
ilepsy receiving renal replacement therapy with dialysis 
and recommend these patients to be submitted to a car-
diological investigation. Strategies, such as taking a de-
tailed cardiovascular history, looking for cardiovascular 
disease, symptoms, cardiovascular risk factors and prior 
cardiac findings (electrocardiogram, echocardiogram and 
holter monitoring) should be developed by a cardiolo-
gist or a general practioner and assess if this could pre-
vent SUDEP although this may require large population-
al studies28.
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